Tanuja N Gengiah
Biographic Data
| ID | 7728639 |
|---|---|
| NAME | Tanuja N Gengiah |
| GIVEN NAMES | Tanuja N |
| FAMILY NAME | Gengiah |
| SIGNATURE | GENGIAH T N |
| AFFILIATIONS | Centre for the AIDS Programme of Research in South Africa |
| ORCID | 0000-0002-3405-5128 |
| VERIFIED | Yes |
| TOTAL WORKS | 7 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 7 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2010 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Evaluating Motivational Interviewing and Peer Adherence Support as Strategies to Improve Oral PrEP Adherence among HIV-Negative Adults in KwaZulu-Natal, South Africa
Consistent adherence is essential for the effectiveness of daily oral pre-exposure prophylaxis (PrEP) in preventing HIV. Motivational interviewing (MI) and peer adherence support (PAS) are adherence support strategies, providing individualized support and may enhance both adherence to oral PrEP and continued use over time. This study aimed to evaluate the impact of implementation-adapted MI and PAS approaches on oral PrEP adherence and identify p…
Written on the Skin
To address challenges associated with the uptake of daily oral pre-exposure prophylaxis (PrEP) by young women at high risk of acquiring HIV, a range of novel, long-acting, slow-release products are being developed and clinically evaluated. One such technology is an annual implant of tenofovir alafenamide (TAF). This study explores the perspectives of participants from a first-in-human trial of an annual TAF implant to inform considerations for fu…
“There is nobody who wouldn’t like to”
A novel long-acting HIV oral pre-exposure prophylaxis (PrEP) implant was first tested in a Phase I clinical trial in South Africa, and this study sought to understand motivations behind trial participants enrolment, highlighting considerations for recruitment in future studies. Qualitative research was conducted using in-depth interviews (IDIs) with 29 study participants, 18 of whom also participated in focus group discussions (FGDs). Participant…
Assessing Adherence to Antiretroviral Therapy in a Rural Paediatric Cohort in KwaZulu-Natal, South Africa
Monitoring Microbicide Gel Use with Real-Time Notification of the Container’s Opening Events
Individualised Motivational Counselling to Enhance Adherence to Antiretroviral Therapy is not Superior to Didactic Counselling in South African Patients
Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women
Vaginal Gel Versus HIV HIV prevention technologies for women are urgently needed, especially in sub-Saharan Africa where young women bear the greatest burden of the HIV epidemic. Abdool Karim et al. (p. 1168 ; published online 19 July) present the results of the CAPRISA 004 randomized control trial. The nearly 3-year-long trial, conducted in urban and rural South African women, tested the efficacy of a vaginal gel containing the antiretroviral dr…
No prominent works on this page.
Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women
Vaginal Gel Versus HIV HIV prevention technologies for women are urgently needed, especially in sub-Saharan Africa where young women bear the greatest burden of the HIV epidemic. Abdool Karim et al. (p. 1168 ; published online 19 July) present the results of the CAPRISA 004 randomized control trial. The nearly 3-year-long trial, conducted in urban and rural South African women, tested the efficacy of a vaginal gel containing the antiretroviral dr…
Monitoring Microbicide Gel Use with Real-Time Notification of the Container’s Opening Events
Individualised Motivational Counselling to Enhance Adherence to Antiretroviral Therapy is not Superior to Didactic Counselling in South African Patients
Assessing Adherence to Antiretroviral Therapy in a Rural Paediatric Cohort in KwaZulu-Natal, South Africa
Evaluating Motivational Interviewing and Peer Adherence Support as Strategies to Improve Oral PrEP Adherence among HIV-Negative Adults in KwaZulu-Natal, South Africa
Consistent adherence is essential for the effectiveness of daily oral pre-exposure prophylaxis (PrEP) in preventing HIV. Motivational interviewing (MI) and peer adherence support (PAS) are adherence support strategies, providing individualized support and may enhance both adherence to oral PrEP and continued use over time. This study aimed to evaluate the impact of implementation-adapted MI and PAS approaches on oral PrEP adherence and identify p…
Written on the Skin
To address challenges associated with the uptake of daily oral pre-exposure prophylaxis (PrEP) by young women at high risk of acquiring HIV, a range of novel, long-acting, slow-release products are being developed and clinically evaluated. One such technology is an annual implant of tenofovir alafenamide (TAF). This study explores the perspectives of participants from a first-in-human trial of an annual TAF implant to inform considerations for fu…
“There is nobody who wouldn’t like to”
A novel long-acting HIV oral pre-exposure prophylaxis (PrEP) implant was first tested in a Phase I clinical trial in South Africa, and this study sought to understand motivations behind trial participants enrolment, highlighting considerations for recruitment in future studies. Qualitative research was conducted using in-depth interviews (IDIs) with 29 study participants, 18 of whom also participated in focus group discussions (FGDs). Participant…
HIV/AIDS Research and Interventions (7 works) · Public health (5 works) · Medicine (4 works) · Adolescent Sexual and Reproductive Health (3 works) · Health psychology (3 works) · Human immunodeficiency virus (HIV (3 works) · Human immunodeficiency virus (HIV) (3 works) · Reproductive tract infections research (3 works) · Viral load (3 works) · Antiretroviral therapy (2 works)